amikacin was studied for clinical effect in 7 patients with acute leukemia , 1 patient with chronic myelogenous leukemia-blastic crisis , 1 patient with malignant lymphoma and 1 patient with aplastic anemia , who were suffered from severe infection such as sepsis , pneumonia or subcutaneous abscess .
C0002499
amikacin
C0036690
sepsis